These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 11734517)
1. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Patel KA; Edmondson ND; Talbot F; Parsons MA; Rennie IG; Sisley K Br J Ophthalmol; 2001 Dec; 85(12):1440-4. PubMed ID: 11734517 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetics and prognosis for uveal melanoma in Korean patients. Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015 [TBL] [Abstract][Full Text] [Related]
3. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
4. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Sisley K; Rennie IG; Parsons MA; Jacques R; Hammond DW; Bell SM; Potter AM; Rees RC Genes Chromosomes Cancer; 1997 May; 19(1):22-8. PubMed ID: 9135991 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
7. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523 [TBL] [Abstract][Full Text] [Related]
8. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614 [TBL] [Abstract][Full Text] [Related]
9. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
10. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Parrella P; Caballero OL; Sidransky D; Merbs SL Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors. Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of chromogenic in situ hybridization for the determination of monosomy 3 in uveal melanoma. Gleeson G; Larkin A; Horgan N; Kennedy S Arch Pathol Lab Med; 2014 May; 138(5):664-70. PubMed ID: 24786124 [TBL] [Abstract][Full Text] [Related]
15. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study. Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812 [TBL] [Abstract][Full Text] [Related]
17. Prognostic parameters in uveal melanoma and their association with BAP1 expression. van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369 [TBL] [Abstract][Full Text] [Related]
18. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997 [TBL] [Abstract][Full Text] [Related]
19. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
20. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma. Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]